| 01 Sept, 10:10 am | m_and_a | 1 | Aurobindo Pharma's wholly owned subsidiary Apitoria Pharma incorporated a new wholly owned subsidiary, Avogent Lifesciences Private Limited, with an initial share capital of Rs 5 crore for manufacturing and marketing operations. | nse |
| 31 Aug, 10:09 am | other | 1 | Aurobindo Pharma's subsidiary Lannett Company LLC announces the launch of a generic version of Advair Diskus in the US. | nse |
| 31 Aug, 10:03 am | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) | bse |
| 28 Aug, 03:36 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Unit-VI of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company. | nse |
| 24 Aug, 09:01 am | — | … | Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Lannett Company LLC, a wholly owned subsidiary of Aurobindo Pharma USA, Inc. | nse |
| 21 Aug, 03:34 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Auro Peptides Ltd, a subsidiary/business arm of the Company. | nse |
| 17 Aug, 07:34 am | — | … | Aurobindo Pharma Limited has informed the Exchange about Classification of US FDA Inspection at Raleigh Plant, North Carolina, owned by Aurolife Pharma LLC, a wholly owned step-down subsidiary of the Company, as Voluntary Action Indicated (VAI). | nse |
| 14 Aug, 09:38 am | — | … | Aurobindo Pharma Limited has informed the Exchange that Unit I of Eugia Pharma Specialities Ltd., received a Warning Letter from US FDA | nse |
| 13 Aug, 06:05 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Transcript | nse |
| 13 Aug, 05:59 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 13 Aug, 04:30 pm | — | … | Intimation of incorporation of a new wholly owned subsidiary. | nse |
| 13 Aug, 04:22 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 07 Aug, 11:56 am | — | … | We are enclosing copies of newspaper advertisement of the financial results of the Company for the first quarter ended June 30, 2026, as published in Business Standard and Nava Telangana on August 7, 2026. | nse |
| 06 Aug, 06:08 pm | — | … | Intimation of participation by the officials of the Company in Investor / Analyst meet to be held on August 11 to 13, 2026 in Singapore & Hong Kong | nse |
| 05 Aug, 08:12 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about proposal of merger of the two wholly owned stepdown subsidiaries with a wholly owned subsidiary of the Company. | nse |
| 05 Aug, 08:09 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Restructuring | bse |
| 05 Aug, 08:02 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 05 Aug, 08:00 pm | — | … | Aurobindo Pharma Limited has informed the Exchange regarding a press release dated August 05, 2026, titled "Press Release on Unaudited Financial Results of the Company for the first quarter ended June 30, 2026.". | nse |
| 05 Aug, 07:57 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 05 Aug, 07:55 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 05 Aug, 07:52 pm | — | … | Aurobindo Pharma Ltd - 524804 - Board Meeting Outcome for Outcome Of The Board Meeting Held On August 5, 2026 | bse |
| 05 Aug, 07:47 pm | — | … | Aurobindo Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 04 Aug, 11:27 am | — | … | Aurobindo Pharma Limited has informed the Exchange about dispatch of a letter providing a web-link of the Integrated Annual Report 2025-26 to those Members who have not registered their e-mail addresses. | nse |
| 04 Aug, 11:15 am | — | … | Aurobindo Pharma Ltd - 524804 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 03 Aug, 06:32 pm | — | … | Aurobindo Pharma Ltd - 524804 - Reg. 34 (1) Annual Report. | bse |
| 29 Jul, 04:53 pm | — | … | Aurobindo Pharma Limited has iIntimated the date of 39th Annual General Meeting of Aurobindo Pharma Limited. | nse |
| 29 Jul, 11:07 am | — | … | Aurobindo Pharma Limited has informed the Exchange about schedule of Earnings Call to be held on August 6, 2026 at 8:30 AM (IST) on Unaudited Financial Results of the Company for the first quarter ended June 30, 2026. | nse |
| 27 Jul, 06:20 pm | — | … | Aurobindo Pharma Ltd - 524804 - Board Meeting Intimation for Intimation Of Board Meeting. | bse |
| 24 Jul, 09:47 pm | — | … | Aurobindo Pharma Limited has informed the Exchange regarding a press release dated July 24, 2026, titled "Aurobindo Pharma signs non-exclusive voluntary license agreement with MSD". | nse |
| 24 Jul, 09:44 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 23 Jul, 09:33 pm | — | … | Aurobindo Pharma Limited has informed the Acquisition of majority ownership control in A1 Biochem Labs (India) Private Limited, India and A1 Biochem Labs LLC, USA . | nse |
| 23 Jul, 09:30 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 21 Jul, 04:35 pm | — | … | Intimation of receipt of ANVISA Approval for Biosimilars Manufacturing Facility of CuraTeQ Biologics Private Limited, a wholly owned subsidiary of the Company. | nse |
| 10 Jul, 01:09 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about incorporation of a new wholly owned stepdown subsidiary in Indonesia. | nse |
| 10 Jul, 01:02 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 02 Jul, 10:36 am | — | … | Aurobindo Pharma Limited has informed the Exchange about completion of of transfer of Company s domestic branded generic pharmaceutical formulations products business to Auropharm Limited, a wholly owned subsidiary of the Company | nse |
| 30 Jun, 09:57 am | — | … | Intimation of completion of Lannett acquisition by Aurobindo Pharma USA Inc., a wholly owned subsidiary of the Company. | nse |
| 30 Jun, 09:54 am | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 27 Jun, 10:38 am | — | … | Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Auroactive Pharma Private Limited, a wholly owned subsidiary of the Company. | nse |
| 25 Jun, 06:43 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Updates on Acquisition | bse |
| 25 Jun, 06:41 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about Acquisition | nse |
| 22 Jun, 07:31 am | — | … | Aurobindo Pharma Limited has informed the Exchange regarding a press release dated Jun 22, 2026, titled "Aurobindo Pharma USA Receives FTC Approval to Acquire Lannett Company". | nse |
| 22 Jun, 07:27 am | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 19 Jun, 09:11 pm | — | … | Aurobindo Pharma Limited has informed the Exchange about General Updates | nse |
| 19 Jun, 09:10 pm | — | … | Aurobindo Pharma Ltd - 524804 - Completion Of US FDA Pre-Approval Inspection (PAI) At Eugia Steriles Private Limited, A 100% Stepdown Subsidiary Of The Company | bse |
| 19 Jun, 04:03 pm | — | … | Aurobindo Pharma Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 19 Jun, 08:28 am | — | … | Aurobindo Pharma Limited has informed that the necessary approval from US Federal Trade Commission (FTC) for the acquisition of the Lannett business has been obtained today. | nse |
| 19 Jun, 08:24 am | — | … | Aurobindo Pharma Ltd - 524804 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. | bse |
| 12 Jun, 06:13 pm | procedural | 0 | Aurobindo Pharma Limited informed the Exchange about a general update, with no substantive business, financial, or event details disclosed in the title provided. | nse |
| 04 Jun, 06:16 pm | — | … | Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |